Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix Phase 2b in Uterine Fibroids
NCT01817530Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of elagolix in Uterine Fibroids (UF), sponsored by AbbVie Inc.. Started Apr 2013; status: completed.
02
Drugs
elagolix
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT01817530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817530.